King Charles made an admission about ageing as he and Queen Camilla visited a popular restaurant in London earlier this week ...

It was earlier this week whilst in attendance at an event at a restaurant in London that the monarch shared an honest ...

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to ...

Initiated the Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 ...

The clinical features of PsA are diverse, comprising both musculoskeletal (peripheral arthritis, spondylitis, dactylitis, and enthesitis) and non-musculoskeletal (skin and nail disease ...

The database was searched for patients with dactylitis. Descriptive statistics were used to describe the population and χ 2 tests to relate dactylitis to radiographic changes. Results: Dactylitis was ...

Significant differences were also observed for risankizumab versus placebo for the first eight ranked secondary endpoints, including skin and nail psoriasis endpoints, minimal disease activity and ...

Total resolution rates for enthesitis, dactylitis and nail psoriasis, at 4 years, were 71%, 81% and 65%, respectively (LOCF). Structural damage progression was low over 4 years’ treatment. No new ...

Rosacea is more common among fair-skinned people ages 30 to 50 years. It's slightly more common in females rather than males. Even so, rosacea can develop at any age, even during childhood. These ...

Spondyloarthritis (SpA), if not diagnosed and treated early, often leads to significant morbidity. Unfortunately, diagnosis and implementation of therapy are frequently delayed, in many cases by ...

Onychomycosis, or fungal infection of the nail, most often affects the toenails. Infected nails usually have a thick, yellow appearance and can become coarse and brittle (see Figure 4). When ...